The increasing isolation ofSerratiaspecies from clinical specimens
- 1 February 1979
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 82 (1) , 31-40
- https://doi.org/10.1017/s0022172400025444
Abstract
A 14-month survey was undertaken in a diagnostic bacteriology laboratory to determine the incidence of Serratia spp. in routine clinical specimens. Gram-negative organisms with enterobacteria-like colonies were tested by a simple screening procedure. Fifty-eight strains of S. marcescens and two strains of S. liquefaciens were isolated from 59 patients. The strains were usually nonpigmented and exhibited multiple antibiotic resistance. Serotyping and determination of bacteriocine sensitivity patterns revealed that the majority of infections were sporadic, although episodes of cross-infection did occur.S. marcescens was considered to contribute significantly to morbidity and mortality in 53% of patients and appears to be of increasing importance in hospital-acquired infections.This publication has 34 references indexed in Scilit:
- A comparison of typing methods forSerratia marcescensEpidemiology and Infection, 1977
- SERRATIA MARCESCENS IN HOSPITAL PRACTICEThe Lancet, 1977
- Amikacin, an Aminoglycoside with Marked Activity against Antibiotic-Resistant Clinical IsolatesThe Journal of Infectious Diseases, 1976
- R Factors from Serratia MarcescensJournal of General Microbiology, 1975
- Serratia marcescensThe Lancet Healthy Longevity, 1973
- CROSS-INFECTION WITH SERRATIA MARCESCENS IN AN INTENSIVE-THERAPY UNITThe Lancet, 1972
- Search for SerratiaJournal of Clinical Pathology, 1971
- Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significancePublished by American Medical Association (AMA) ,1970
- Fatal transfusion reaction due to Serratia marcescensJournal of Clinical Pathology, 1967
- Cross-infection withSerratia marcescensJournal of Clinical Pathology, 1962